# US 2026/0265798 A1 · Enzymes and Uses in Biocatalytic Halogenation of N-Heteroaryls Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0265798 A1
- Document ID: US20260265798A1
- Status: Published application
- Kind: A1
- Application number: 18/867,802
- Filed: 2023-05-19
- Published: 2026-09-10
- Earliest claimed: 2022-05-20
- Applicants: Agency for Science, Technology and Research
- Inventors: Yee Hwee LIM; Ee Lui ANG; Fong Tian WONG; Guangrong PEH; Song Buck TAY
- Web page: https://patentgrep.com/patent/US20260265798A1

## CPC

- C12P 17/10: Nitrogen as only ring hetero atom
- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/88: Lyases (4.)
- C12P 17/16: containing two or more hetero rings {(thiamine open chain analogs C12P17/167, i.e. not condensed among themselves or through a common carbocyclic ring system)}
- C12P 17/165: {Heterorings having nitrogen atoms as the only ring heteroatoms}
- C12Y 114/14: with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
- C07D 207/34: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 231/16: Halogen atoms or nitro radicals
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07K 2319/00: Fusion polypeptide
- C07K 2319/21: containing a His-tag
- C12R 2001/39: Pseudomonas fluorescens
- C12Y 402/01001: Carbonate dehydratase (4.2.1.1), i.e. carbonic anhydrase
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present disclosure concerns enzymes and their uses in biocatalytic halogenation of pyrrolic heterocycles thereof. The method of halogenating a 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof comprises contacting the N-heteroaryl or derivative thereof with a halogen and a flavin-dependent halogenase under co-enzyme regeneration conditions in order for the halogen to be substituted at a 4′ position on the N-heteroaryl or derivative thereof.

## Claims

### Claim 1

A method of halogenating a 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof, comprising:
a) contacting the N-heteroaryl or derivative thereof with a halogen and a flavin-dependent halogenase under co-enzyme regeneration conditions in order for the halogen to be substituted at a 4′ position on the N-heteroaryl or derivative thereof;
wherein the co-enzyme regeneration conditions comprises flavin adenine dinucleotide (FAD) at about 0.01 equivalents to about 0.2 equivalents relative to a flavin-dependent halogenase concentration;
E. coli flavin reductase (Fre) at about 0.1 equivalents to about 0.5 equivalents relative to a flavin-dependent halogenase concentration;
nicotinamide adenine dinucleotide hydrogen (NADH) at about 2 equivalents to about 250 equivalents relative to a flavin-dependent halogenase concentration;
glucose 1-dehydrogenase (GdHi) at about 0.1 equivalents to about 0.5 equivalents relative to a flavin-dependent halogenase concentration;
monosaccharide at about 5 equivalents to about 500 equivalents relative to a flavin-dependent halogenase concentration.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the co-enzyme regeneration conditions comprises NADH at about 0.05 equivalents to about 5 equivalents relative to a 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof concentration; and/or
wherein the co-enzyme regeneration conditions comprises monosaccharide at about 5 equivalents to about 20 equivalents relative to a 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof concentration.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The method according to claim 1, wherein a ratio of FAD:Fre:GDH is about 1:2.5:2.5; and/or
wherein a ratio of FAD:Fre:NADH:GDH is about 1:2.5:2500:2.5.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method according to claim 1, wherein the co-enzyme regeneration conditions further comprises a halogen at about 10 equivalents to about 30 equivalents relative to a 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof concentration.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the halogen is derived from a halide, the halide selected from Cl− or Br−.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the co-enzyme regeneration conditions further comprises a phosphate buffer or a Tris HCl buffer.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the flavin-dependent halogenases is monodechloroaminopyrrolnitrin halogenase (PrnC).

### Claim 10 (depends on 1)

The method according to claim 1, wherein the flavin-dependent halogenases comprises a N-terminal 11 amino acid solubility tag;
wherein the N-terminal 11 amino acid solubility tag is derived from a first 11 amino acid residues within a N-terminal N-half domain of a duplicated carbonic anhydrase (dCA) from Dunaliella species.

### Claim 11

(canceled)

### Claim 12 (depends on 10)

The method according to claim 10, wherein the 11 amino acid solubility tag has an amino acid sequence of VSEPHDYNYEK.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the N-heteroaryl or derivative thereof is a 5 membered N-heteroaryl or derivative thereof.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the substituent on the 2′, 3′ and/or 5′ substituted N-heteroaryl or a derivative thereof is each selected from optionally substituted aryl or optionally substituted heteroaryl.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the N-heteroaryl or derivative thereof is a compound of formula (I)
wherein X is selected from CR2 or N;
R1 is H, optionally substituted aryl, or optionally substituted heteroaryl;
R2 is H, optionally substituted aryl, or optionally substituted heteroaryl;
R3 is H, optionally substituted aryl, or optionally substituted heteroaryl;
wherein at least one of R1, R2 and R3 is optionally substituted aryl or optionally substituted heteroaryl; or
R1 and R2 are linked to form optionally substituted aryl, or optionally substituted heteroaryl.

### Claim 16

(canceled)

### Claim 17 (depends on 15)

The method according to claim 15, wherein when X is CR2, R2 is H and R3 is H.

### Claim 18 (depends on 15)

The method according to claim 15, wherein when X is N, R1 is H.

### Claim 19 (depends on 1)

The method according to claim 1, wherein the N-heteroaryl or derivative thereof is selected from:

### Claim 20 (depends on 1)

The method according to claim 1, wherein the halogenated N-heteroaryl or derivative thereof is (where X1 represents halo):

### Claim 21 (depends on 1)

The method according to claim 1, wherein the method is characterised by at least one of the following:
a) a regioisomeric ratio of 4′ substitution to 2′, 3′ or 5′ substitution is about 3:1 to about 1.1:1;
b) a ratio of 4′ monohalogenation to 2′, 4′ dihalogenation, 3′, 4′ dihalogenation, and/or 4′, 5′ dihalogenation of about 20:1 to about 4:1;
c) a Kcat of about 7×10−3 s−1 to about 8×10−3 s−1;
d) a Km of about 1×10−5 M to about 2×10−5 M; and
e) a Kcat/Km of about 4×102 s−1 M−1 to about 5×102 s−1 M−1.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26

A method of producing a flavin-dependent halogenase, comprising:
a) expressing the flavin-dependent halogenase in a cell;
wherein the flavin-dependent halogenase comprises an 11 amino acid solubility tag at a N-terminus thereof and a His6 tag at a C-terminus thereof.

### Claim 27 (depends on 26)

The method according to claim 26, further comprising a step of purifying the flavin-dependent halogenase by metal affinity chromatography.

### Claim 28

A method of synthesising Fludioxonil, comprising:
a) contacting a compound of formula (II) or derivative thereof with a halogen and a flavin-dependent halogenase under co-enzyme regeneration conditions in order for the halogen to be substituted at a 4′ position on the compound or derivative thereof;
wherein the co-enzyme regeneration conditions comprises flavin adenine dinucleotide (FAD) at about 0.01 equivalents to about 0.2 equivalents relative to a flavin-dependent halogenase concentration;
E. coli flavin reductase (Fre) at about 0.1 equivalents to about 0.5 equivalents relative to a flavin-dependent halogenase concentration;
nicotinamide adenine dinucleotide hydrogen (NADH) at about 2 equivalents to about 250 equivalents relative to a flavin-dependent halogenase concentration;
glucose 1-dehydrogenase (GdHi) at about 0.1 equivalents to about 0.5 equivalents relative to a flavin-dependent halogenase concentration;
monosaccharide at about 5 equivalents to about 500 equivalents relative to a flavin-dependent halogenase concentration; and
b) contacting the 4′ halogenated compound of step a) with a palladium precatalyst and a cyanide precursor.
